A cross-species drug-discovery platform to accelerate the identification of lifespan-extending interventions
What this study shows
An integrated high-throughput lifespan-screening platform spanning yeast, nematodes, flies, killifish and mice, evaluating >400 compounds across thousands of conditions using automated imaging and deep-learning death detection. Cross-species integration identifies geroprotectors active in multiple species and shows convergence on known and novel conserved longevity pathways. Methodological infrastructure for the question the Atlas keeps running into: which single-species lifespan results actually generalise. Note the abstract does not name individual hit compounds, so the specific standing of rapamycin/mTOR in this screen cannot be read off the abstract alone.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Five model organisms: S. cerevisiae, C. elegans, D. melanogaster, killifish, mice); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Five model organisms: S. cerevisiae, C. elegans, D. melanogaster, killifish, mice |
| Journal | Cell Reports |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1016/j.celrep.2026.117897 · PMID 42671914 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | >400 small-molecule compounds screened for lifespan extension |
| Target | Conserved longevity pathways (cross-species geroprotector screen) |
| Model | Yeast, C. elegans, D. melanogaster, killifish, mouse |
| Effect | Cross-species screening identifies multi-species geroprotectors and reveals convergence on conserved longevity pathways |
In the Atlas
Related topics
More studies on this topic
- Disruption of the insulin/IGF-1 signaling pathway in Caenorhabditis elegans dramatically increases male longevity and enhances reproductive health late in life (2026)
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice (2011)
- Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice (2016)
- Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls (2014)
Thank you. Your answer was counted anonymously.